Delivery Order SPE2DR25D1202-SPE2DR26F73QF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,400.08 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on December 17, 2025, with completion scheduled for December 18, 2025. This is a firm fixed price, non-set-aside competitive award to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.40 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be performed at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $3,900.48 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,335.72 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 units) on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price, non-set-aside contract is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order as a child...
- The Defense Logistics Agency awarded a $2,767.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Promethegan 12.5 mg suppositories (12-count) on December 18, 2025, with completion scheduled for December 19, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Promethegan 25 mg suppositories (12-count units) with a ceiling value of $14,649.54. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive award issued under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,950.24 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December...
- The Defense Logistics Agency awarded a $1,852.24 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-pack) with a firm fixed price contract type. This is a non-set-aside award issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under...
- The Defense Logistics Agency awarded a $4,446.72 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73QFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,453.79 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count unit) on January 5, 2026, with an ultimate completion date of January 6, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a routine transaction under AmerisourceBergen Drug Corp's substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valid through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs for military and veteran healthcare systems, supplying a comprehensive range of medications and medical supplies across multiple therapeutic domains. The company's role as a prime vendor supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle that enables rapid fulfillment of pharmaceutical requirements across global military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/4/26 |